These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 6281335)

  • 41. Production and characterization of monoclonal antibodies against different epitopes of Ebola virus antigens.
    Shahhosseini S; Das D; Qiu X; Feldmann H; Jones SM; Suresh MR
    J Virol Methods; 2007 Jul; 143(1):29-37. PubMed ID: 17368819
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Glycosylation of the hemagglutinin-neuraminidase glycoprotein of human parainfluenza virus type 1 affects its functional but not its antigenic properties.
    Gorman WL; Pridgen C; Portner A
    Virology; 1991 Jul; 183(1):83-90. PubMed ID: 1647078
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Monoclonal antibodies to dengue virus 4: the spectrum of the reactivity to 4 serotypes of dengue].
    Pupo Antúnez M; Alvarez Vera M; Soto Hernández M; Rodríguez Sánchez H; Rodríguez Díaz R; Morier Díaz L; Guzmán Tirado MG
    Rev Cubana Med Trop; 2000; 52(2):119-25. PubMed ID: 11107906
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of isotype and epitope specificity of monoclonal antibody mixtures in immunodiffusion reactions.
    Griffiths BW; Godard A; Caron JA; Tostowaryk W
    Immunology; 1987 Apr; 60(4):491-6. PubMed ID: 2438204
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Competitive binding of neutralizing monoclonal and polyclonal IgG to the HA of influenza A virions in solution: only one IgG molecule is bound per HA trimer regardless of the specificity of the competitor.
    Taylor HP; Dimmock NJ
    Virology; 1994 Nov; 205(1):360-3. PubMed ID: 7975232
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mice lacking CD8+ T cells develop greater numbers of IgA-producing cells in response to a respiratory virus infection.
    Hyland L; Hou S; Coleclough C; Takimoto T; Doherty PC
    Virology; 1994 Oct; 204(1):234-41. PubMed ID: 8091654
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serological and phylogenetic evidence of monotypic immune responses to different mumps virus strains.
    Rubin S; Mauldin J; Chumakov K; Vanderzanden J; Iskow R; Carbone K
    Vaccine; 2006 Mar; 24(14):2662-8. PubMed ID: 16309801
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The role of the individual cysteine residues in the formation of the mature, antigenic HN protein of Newcastle disease virus.
    McGinnes LW; Morrison TG
    Virology; 1994 May; 200(2):470-83. PubMed ID: 8178436
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interactions of a nonneutralizing IgM antibody and complement in parainfluenza virus neutralization.
    Vasantha S; Coelingh KL; Murphy BR; Dourmashkin RR; Hammer CH; Frank MM; Fries LF
    Virology; 1988 Dec; 167(2):433-41. PubMed ID: 2849234
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neutralization and infection-enhancement epitopes of influenza A virus hemagglutinin.
    Tamura M; Webster RG; Ennis FA
    J Immunol; 1993 Aug; 151(3):1731-8. PubMed ID: 7687637
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mechanisms of rabies virus neutralization.
    Flamand A; Raux H; Gaudin Y; Ruigrok RW
    Virology; 1993 May; 194(1):302-13. PubMed ID: 7683158
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunoglobulin G subclass antibody responses in influenza A and parainfluenza type 1 virus infections.
    Julkunen I; Hovi T; Seppälä I; Mäkelä O
    Clin Exp Immunol; 1985 Apr; 60(1):130-8. PubMed ID: 2988830
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Monoclonal antibodies to newcastle disease virus: delineation of four epitopes on the HN glycoprotein.
    Iorio RM; Bratt MA
    J Virol; 1983 Nov; 48(2):440-50. PubMed ID: 6194312
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antigenic structure, function, and evolution of the hemagglutinin-neuraminidase protein of human parainfluenza virus type 1.
    Henrickson KJ; Savatski LL
    J Infect Dis; 1997 Oct; 176(4):867-75. PubMed ID: 9333143
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Parainfluenza-3 virus: difference in capacity of neuraminidase-weak and strong strains to infect young calves and to elicit cellular immune response.
    Bergman R
    Res Vet Sci; 1978 Sep; 25(2):193-9. PubMed ID: 214834
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Monoclonal antibodies against human paramyxovirus type 3 and against SV5 virus: preparation and preliminary characterization.
    Goswami KK; Russell WC
    J Gen Virol; 1983 Aug; 64 (Pt 8)():1663-72. PubMed ID: 6192203
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Monoclonal antibodies to human parainfluenza virus type 1 detect major antigenic changes in clinical isolates.
    Henrickson KJ
    J Infect Dis; 1991 Dec; 164(6):1128-34. PubMed ID: 1659598
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A comparison of two anti-neuraminidase monoclonal antibodies by complement activation.
    Holmes KT; Hampson AW; Raison RL; Webster RG; O'Sullivan WJ; Mountford CE
    Eur J Immunol; 1982 Jun; 12(6):523-6. PubMed ID: 7117362
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Human parainfluenza virus type 1 evolution combines cocirculation of strains and development of geographically restricted lineages.
    Hetherington SV; Watson AS; Scroggs RA; Portner A
    J Infect Dis; 1994 Feb; 169(2):248-52. PubMed ID: 7508966
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antigenic and structural properties of the hemagglutinin-neuraminidase glycoprotein of human parainfluenza virus type 3: sequence analysis of variants selected with monoclonal antibodies which inhibit infectivity, hemagglutination, and neuraminidase activities.
    van Wyke Coelingh KL; Winter CC; Jorgensen ED; Murphy BR
    J Virol; 1987 May; 61(5):1473-7. PubMed ID: 2437318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.